Press Releases
Applied Molecular Transport to Report Top-line Phase 2 Results from MARKET Combination Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative Colitis
Jul 05, 2022
Applied Molecular Transport to Present at Upcoming June Investor Conferences
Jun 02, 2022
Applied Molecular Transport Provides Strategy Update
May 18, 2022
Applied Molecular Transport Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 09, 2022
Applied Molecular Transport to Present at BofA Securities 2022 Healthcare Conference
May 05, 2022
Applied Molecular Transport Announces Positive Top-line Phase 2 Results from FILLMORE Trial of Oral AMT-101 in Patients with Chronic Pouchitis
Apr 25, 2022
Applied Molecular Transport to Report Top-line Phase 2 Results from FILLMORE Trial of Oral AMT-101 in Patients with Chronic Pouchitis
Apr 24, 2022
Applied Molecular Transport Announces Publication in Tissue Barriers Providing Additional Insight into Company’s Proprietary Technology Platform
Apr 13, 2022
Applied Molecular Transport Appoints Charlene Banard to its Board of Directors
Apr 06, 2022
Applied Molecular Transport Appoints Industry Veteran Carolyn Finkle as Senior Vice President, Head of Regulatory Affairs
Mar 14, 2022
Displaying 1 - 10 of 13